Summary Over a 10 year period, between 1974-1984, 257 adult cases of tissue sarcoma have been evaluated in the Department of Medical Oncology, Christie Hospital, Manchester. At registration locally advanced or metastatic diseases was present in 162 (63%). The male/female ratio was 1.5:1 and median age 54 years (range 14-85). The commonest sites were lower limb (33%), visceral (21%), trunk (13%), retroperitoneum (12%) and upper limb (10%). Leiomyosarcoma (27%), liposarcoma (14%) malignant fibrous histiocytoma (10%) and neuro plus fibrosarcomas (15%) were the most frequent histological subtypes. A high proportion of uterine sarcomas (17%) is a point of distinction from many other series. Histological grade was specified in 72% of cases and the distribution (Grade 1-27%; 11-6%; 111-67%) reflected a referral bias towards advanced disease. Local resection of the primary tumour was performed in 76% of cases.In many instances this only amounted to 'shelling out' and true compartmental excisions were rare. Amputation was performed in 31% of patients with limb sarcomas. Ninety-eight patients (38%) had experienced one or more local recurrences prior to referral and the overall local recurrence rate was 56%. Suitable patients (78%) received chemotherapy, 50% entering multicentre trials in collaboration with the EORTC. The commonest regime used in patients with advanced disease was CYVADIC which produced an overall response rate of 37%. Ifosfamide, used as a single agent in 16 patients, induced 3CR and 5PR for an overall response rate of 50%.
The extensive literature on soft tissue sarcoma is disproportionate to their incidence -less than 1% of all malignant tumours. Although primary management is usually surgical, their ubiquitous distribution in the body means that these tumours present to several disciplines. Many simulate more common benign tumours, and highly variable histological appearances can make diagnosis difficult. Although radical surgery may achieve local control, combined modality therapy may allow a more conservative approach, and addresses the problem of metastases. Referral to specialist centres, where there is interest and expertise in the management of these tumours, is therefore desirable.
The surgical management, particularly of limb sarcomas, has been explored in a number of large series (Shiu et al., 1975; Simon & Enneking, 1976; Rantokokko & Ekfors, 1979 , Markhede et al., 1982 and the relationship of local recurrence to adequacy of resection is clearly defined. Series of sarcomas at specific sites (Braund & Pigott, 1962; Salazar et al., 1978a; Cody et al., 1981; Gerson et al., 1982) have been reported. Conservative surgery combined with adjuvant radiotherapy given pre- (Suit et al., 1981) or post-operatively (Lindberg et al., 1981; Weisenburger et al., 1981 , Rosenberg et al., 1982 has been extensively studied. More recently the role of chemotherapy, in an adjuvant setting (Sordillo et al., 1981; Weisenburger et al., 1981; Das Gupta et al., 1982; Rosenberg et al., 1982; Edmonson et al., 1982) or for advanced disease (Gottlieb et al., 1975; Baker et al., 1979; Yap et al., 1981; Presant et al., 1981; Saiki et al., 1982; Borden et al., 1983) has been evaluated in large multi-centre trials.
In the UK a number of authors (Cade, 1951; Windeyer et al., 1966; Spittle et al., 1971; Coe et al., 1981) have examined the role of post-operative radiotherapy in the conservative management of primary sarcomas. The Royal Marsden hospital has reviewed its experience in the chemotherapy of advanced disease between 1973 (Wiltshaw et al., 1979 Although patients were occasionally referred for an opinion after biopsy of the primary tumour before definitive surgery, the majority were seen after excision of the primary tumour, or when local recurrence or metastatic spread was evident.
Eligible The majority of patients receiving chemotherapy or radiotherapy have been followed in out-patient clinics, and for those that have died, the date and cause are known. Information on the remaining patients has been obtained through their general practitioner, referring hospitals, and registration of cancer deaths through the office of Population, Census and Surveys (OPCS), or the National Health Service central registry. Definition of response are those outlined by the World Health Organisation (WHO 1979) .
Analysis of survival from date of first surgical operation was carried out by the Log-Rank method (Peto et al., 1975) .
Results
During the 10 year period, [1974] [1975] [1976] [1977] [1978] [1979] [1980] [1981] [1982] [1983] [1984] 257 documented cases of soft tissue sarcoma have been evaluated. At registration, 162 patients had locally advanced or metastatic disease, while the remaining 95 were referred after definitive surgery for the primary tumour or a local recurrence. The pattern of referral according to year is shown in Figure 1 . Patient characteristics There were 154 males, 103 females, with a median age (at the time of diagnosis of the primary tumour) of 54 years, range 14-85. Presenting symptoms are shown in Table I , the commonest being a mass (79%) which had ulcerated in 4 cases and was associated with pain, in 43% of cases. The mean and median durations from first symptoms to definitive treatment of the primary tumour were 12 and 5 months respectively but the range, 0-238 months, was wide.
The commonest sites were lower limb (33%) visceral (21%), trunk (13%), retroperitoneum (12%) and upper limb (10%). Table II presents the  distribution of histological type according to site,  and Table III provides more detailed information (Figure 2 ), those patients with sarcomas > 100 cms2 faring considerably worse (P<0.01). (Table VIII) . Twenty-five patients received this combination, but pathological material could not be reviewed for three, and there was one early death from malignant disease occuring at 2 weeks. There were 3CR (14%) and 7PR (33%), giving overall response rate of 47%. Durations of remission were: CR 9, 11, 16 months; PR -median 9 months, range 4-27. In 1982 a small pilot study of alternating chemotherapy (Ifos/MTX VADIC Table VIII) was initiated. Ten consecutive patients were entered into this study, instead of EORTC protocols, and a further 3 patients who lacked clinically measurable disease (but could be evaluated by computed tomography) have been added. There was one early (Table VIII) . The results of this study have been published elsewhere (Pinedo et al., 1984) , and are compared in Table IX with the results from this centre.
Between 1st March 1980 and 25th June 1983 two randomised phase II studies comparing the new anthracyclines Carminomycin (Bramwell et al., 1983) and 4'Epiadriamycin with Adriamycin (Table VIII) were completed. (Figure 5 ). Local recurrence (Figure 6 ) also had an unfavourable association with survival (P<0.03). Considering only low grade tumours (51 cases), males seemed to fare slightly better (P=0.6) and the age differences were still significant. Although low grade sarcomas of the trunk and viscera appeared to be associated with a better prognosis than those in the limbs, and survival seemed worse for retroperitoneal and intrathoracic tumours, the numbers in each group were small and these differences were not significant. It is worth comment that all 4 patients with small (<25cm2) grade I tumours are alive. There were no significant differences in the other six categories. As in the overall analysis, local recurrence and histological States. An anlysis of these cases has been published (Russell et al., 1977 ) and the present series will be compared with this, with occasional reference to relevant British series.
A male to female ratio of 1.5: 1 is unusual, most large series reporting an equal distribution, and there is no clear reason for this bias. The median age, 54 years, is higher than that in the AJC series -43 years -but agrees with a report of 191 cases collected by the National Soft Tissue Sarcoma Registry (Mettlin et al., 1982) in which the median age was 58.5 years.
Most patients (79%) presented with a mass. In many cases it was painless, but vague aching discomfort often occurred. Severe pain was uncommon, but a limb sarcomas was often associated with neurological deficit due to pressure on major nerves. The high incidence of vaginal bleeding (13%), urinary symptoms and abdominal distension reflects inclusion of a significant proportion (16%) of uterine sarcomas. Although common with metastatic disease, respiratory symptoms from primary sarcomas were rare, but in one patient haemoptysis due to lung metastases led to the discovery of an asymptomatic primary uterine sarcoma. Delay in diagnosis is illustrated by the wide range (0-238 months) and long mean interval (12.4 months) between first symptoms and definitive treatment of the primary tumour, as patients (and sometimes their doctors) often ignored painless lumps until other symptoms supervened.
In comparison with the AJC series and that of Cade (1951) there were fewer extremity tumours, 44% vs. 52-53%. Higher proportions of limb sarcomas, 66-71 %, were present in two British radiotherapy series (Windeyer et al., 1966 , Coe et al., 1981 . Visceral sarcomas which comprised the second largest group in our series are not separately classified in the AJC report, and it is not clear whether they have been included with sarcomas of the trunk or completely excluded. Tumours of the thigh and buttock, together with retroperitoneal sarcomas predominate in all large series of soft tissue sarcomas, and this is no exception. In agreement with other series, liposarcomas predominate in the thigh and buttock (26%) and we concur with other findings in the AJC report eg. leiomyosarcoma is the commonest histological type in the retroperitoneum (40%) and synovial sarcoma is predominantly a tumour of the lower extremity -11 of 13 cases. The four dominant histological types in most early surgical and pathological series (Shiu et al., 1975 , Gerner & Moore, 1975 and Rosenberg & Glatstein, 1983 including the AJC study are fibrosarcoma, liposarcoma and rhabdomyosarcoma. Malignant fibrous histiocytoma is becoming increasingly recognised as a separate entity (Weiss & Enzinger 1978; Rantakokko Ekfors, 1979; Kearney et al., 1980) , and features in the AJC series. It is likely that many cases previously classified as fibrosarcoma or rhabdomyosarcoma now fall into this group. In 1978 the South West Oncology Group published the results of a pathological review of 130 cases entered into a chemotherapy trial for advanced disease (Baker & Benjamin 1978) . Malignant fibrous histiocytoma (22%), leiomyosarcoma (20%) and fibrosarcoma (10%) were the commonest histological subtypes. The EORTC have found a similar distribution in their CYVADIC study (Pinedo et al., 1984) . In view of the high proportion of patients with advanced disease at presentation to the Christie (64%), and the high incidence of visceral sarcomas, it is not surprising that leiomyosarcoma (26%), liposarcoma (14%) and malignant fibrous histiocytoma (11%) are the dominant histological subtypes in this series. Malignant fibrous histiocytoma is probably under-represented as cases in this study have been reviewed over a 10 year time period. Fibrosarcoma, synovial sarcoma and rhabdomyosarcoma were the commonest histological diagnoses among sarcomas of the extremities seen at the Christie in the 20 years preceding this study (unpublished data). In any series biased towards advanced disease, there is likely to be a greater proportion of high grade tumours (67% in this series). Intermediate grade sarcomas were uncommon (6%) and their division from high grade tumours seems to have little clinical significance.
Some studies (Suit et al., 1975; Weiss & Enzinger, 1978 , Rantakokko & Ekfors, 1979 have suggested that size is related to prognosis, although others disagree (Markhede et al., 1982) . In their proposal for a new staging system, Russell et al. (1977) (Table VIII) . The overall response rate among all patients entered into EORTC protocol 62761 was 38%, but for Christie patients entering the trial (32% of the total evaluable) it was lower at 30%. In contrast, the response rate in the Christie pilot study was 47%. If all Christie patients are combined the response rate is 37%. Although overall response to the S2 split regime was disappointing, 2 patients with the most durable complete remissions (39, 54 months) received this form of chemotherapy. In the anthracycline studies, the response rate to Adriamcyin among Christie and EORTC trial patients was remarkably consistent between 25-29%. In protocol 62801, there was no significant difference in response rate between 4'Epiadriamycin and Adriamycin, although the former was slightly less toxic ), but we did not obtain any responses in 7 evaluable patients. In contrast we observed the only remission on Carminomycin in protocol 62802 (Table X) .
Our response rate (50%) to a new alkylating agent, Ifosfamide, is very encouraging. Even if one complete remitter with Ewing's sarcoma of soft tissues, a highly responsive tumour, is removed the results are similar to these reported from the Royal Marsden (Stuart-Harris et al., 1983) . Although the numbers are small, they are supported by data from the 13 patients receiving Ifosfamide in combination with Methotrexate, 6 of whom have responded.
In most chemotherapy trials, no significant differences in response according to histological subtype have emerged because of relatively low response rates and small numbers in each group (Pinedo et al., 1984; Presant et al., 1981; Schoenfeld et al., 1982) . Reporting results in 125 patients, found neurofibrosarcoma, rhabdomyosarcoma, leiomyosarcoma, fibrosarcoma and angiosarcoma to be most responsive, which conflicts with our findings. It is likely that in both studies these differences have occurred by chance.
Considering adjuvant chemotherapy, data from the small pilot study of VAC chemotherapy are difficult to interpret. The numbers are small and there is no comparative control group. Patients at high risk for recurrence -eg. tumour spillage at/ operation, sites where radical resection was difficult, high grade tumours -were given adjuvant therapy, but local relapse has occurred in 29% and metastasis in 47% of cases. The EORTC adjuvant trial 62771 is still accruing patients and it is premature to report results. Among the Christie entries fewer patients have developed metastatic disease in the chemotherapy arm, 3 compared with 9 in the control arm, (although there was one chemotherapy death). This reduced incidence of metastases is in agreement with two randomised studies of adjuvant chemotherapy reported in the United States (Edmonson et al., 1982; Rosenberg et al., 1983) , but it would be unwise to draw firm conclusions from a small subgroup of a larger randomised trial which is still in progress. Followup is too short to exclude the possibility that postponement of recurrence due to chemotherapy is responsible for the observed difference. Criteria for ensuring that patients were truly disease free at entry into protocol 62771 were much stricter than for the VAC study. Survival is similar in both arms but there have been few events. Difficulties have been encountered in administration of the prescribed chemotherapy, either due to myelosuppression or patients' refusal because of vomiting and alopecia. Although it is possible that our case of acute myeloid leukaemia was induced by chemotherapy, the short time interval, normal karyotype and good response to chemotherapy are atypical features of secondary leukaemia.
Although soft tissue sarcomas have often been considered radioresistant, there are many accounts in the literature of good regressions, and even "cures" of primary tumours, and satisfactory palliation of metastatic disease using radiotherapy (McNeer et al., 1968 , Suit & Russell, 1975 . In this study the results of irradiating inoperable primary tumours were poor, but some of these were large retroperitoneal tumours placing restrictions on the tolerable dose. The rate of local control following radical post-operative radiotherapy (64%) was disappointing, although similar to another British series (Coe et al., 1981) , in comparison with some reports (Rosenberg et al., 1981b , Lindberg et al., 1981 , Liebel et al., 1981 , but this was an unselected group of patients with tumours at all sites. Inadequate prior surgery, often limited to excisional biopsy, may have influenced the results.
The high rate of metastasis (62%) and poor survival (38%) is biased by referral patterns. A few patients were moribund at the time of presentation to the Christie. Remissions in excess of 2 years have been observed in only 4 patients with metastatic disease, one relapse occurring after four and a half years. Unfortunately we have not seen remissions continuing beyond 5 years as reported by Yap et al. (1983) . The results of current regimes of combination chemotherapy remain disappointing, and new approaches are desparately needed. As soft tissue sarcomas have a propensity for relapse in the lungs, which may be the only site of disease, combined surgery and chemotherapy is often feasible and good results have been reported , Karakousis et al., 1982 . To date we have treated 7 patients in this way, 3 of whom are disease free (one requiring a second thoracotomy) although the remaining 4 have relapsed and died. We intent to pursue this line of management in suitable patients.
Rhabdomyosarcomas and synovial sarcomas are usually considered to be aggressive tumours of high metastatic potential (Morton & Eilber, 1982 , Enzinger & Weiss 1983 ). This has been confirmed in this series. For fibrosarcomas, a high rate of local recurrence but reduced incidence of metastases is consistent with other reports (Pritchard et al., 1974 , Enzinger & Weiss 1983 ), but the numbers are small. Although pleomorphic liposarcomas often disseminate, well differentiated and myxoid types are more common and a reduced incidence of metastasis in this series is consistent with other reports (Reszel et al., 1966 , Enzinger & Weiss, 1983 . Leiomyosarcomas of the uterus, particularly those of high grade, have a dismal prognosis (Spiro & Koss 1965 , Hart & Billman 1978 , confirmed in this series. Uterine mixed mesodermal sarcomas seemed to do particularly badly whereas endometrial stromal sarcomas fared better, but numbers were small. Salazar and coworkers (1978b) showed a higher rate of relapse in mixed mesodermal compared with leiomysarcomas of the uterus, although the former usually presented at a more advanced stage. Problems associated with radical removal account for high rates of local recurrence in the head and neck and retroperitoneum, and many patients probably die of local disease before they can develop metastases.
In this study, the most significant factor influencing survival was histological grade, a finding that has been extensively documented in the literature (Markhede et al., 1982 , Rantakokko & Ekfors, 1979 Russell et al., 1977; Shiu et al., 1975 , Rosenberg & Glatstein, 1983 and Suit et al., 1975 . Russell et al. (1977) , reporting an analysis of the AJC series of 1215 cases, proposed a staging system principally based on this factor. The other significant prognostic factors in this series were primary site and size. As limb and visceral sarcomas are more amenable to radical resection than tumours of the head, neck and trunk, their better prognosis is not surprising and is well documented (Lindberg et al., 1975; Rosenberg et al., 1981b) . The relevance of size has been discussed earlier. Local recurrence was correlated with a poorer survival and is in agreement with much of the published literature. The finding that histological subtype is unimportant, particularly when the influence of grade is removed, is consistent with the published literature, and reflects uncertainties in determining histogenesis in many tumours. For high grade tumours amputation was associated with a better outcome than local resection. The number of patients with low grade tumours treated by amputation was too small to assess the relative merits of these procedures. The better overall survival for younger individuals was not evident for high grade tumours. Younger patients may be more likely to receive radical treatment which may influence survival for low grade tumours. A high rate of metastasis in grade III tumours, with ultimate demise of the patient, is unlikely to be related to age.
As anticipated the commonest first site of metastasis was pulmonary, occurring in 58% of cases. Intraabdominal disease usually took the form of peritoneal and omental seeding from visceral tumours, although it was not always possible to determine the exact sites of tumour. At least initially, other sites such as lymph nodes, liver and bone were less common, although we know from post mortem studies that utlimately widespread dissemination may occur (Kavanagh 1980 ) and even cerebral metastases are more common after chemotherapy (Bryant & Wiltshaw 1980; Espana et al., 1980) .
